|
MEGLUMINE (Methylglucamine)
|
|
28
|
3529
|
March 16, 2026
|
|
EMA proposes GMP update to EudraLex to address nitrosamine impurities
|
|
14
|
956
|
February 20, 2026
|
|
Available Tools for Prediction of Potential Degradation Products from Nitrosation Reactions
|
|
4
|
247
|
February 4, 2026
|
|
N-nitroso-rivaroxaban amide
|
|
7
|
1911
|
February 4, 2026
|
|
Limit of Common or Small Nitrosamine Impurities in RSM irrespective of any particular MDD
|
|
9
|
300
|
January 21, 2026
|
|
How to determine the AI limit value and LOQ when MDD is less than 880mg?
|
|
1
|
162
|
January 20, 2026
|
|
How to Establish MDD for Creams and Ophthalmic Solutions
|
|
4
|
335
|
January 8, 2026
|
|
Nitrosamine Purge Factor Calculation
|
|
1
|
434
|
December 30, 2025
|
|
Nitrosamines in macrocyclic antibiotics
|
|
2
|
230
|
December 10, 2025
|
|
Levetiracetam_Presence of Nitrosamines
|
|
0
|
130
|
December 9, 2025
|
|
FDA Approves Reformulated Ranitidine - Nitrosamine Impurities - NDMA
|
|
3
|
466
|
November 27, 2025
|
|
Peptide Synthesis - Does anyone have experience with potential Nitrosamine impurities coming from solid phase synthesis?
|
|
1
|
199
|
October 16, 2025
|
|
👨💻 Quantitative Analysis of N-Nitrosodimethylamine (NDMA), N-Nitrosodiethylamine (NDEA), and -Nitroso-N-methyl-4-aminobutyric acid (NMBA) in Losartan Potassium Tablets by Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry
|
|
1
|
357
|
September 24, 2025
|
|
Nitrosamine CPCA
|
|
5
|
375
|
September 18, 2025
|
|
👨💻 Quantitative Analysis of NDMA, N-Nitroso-l-ephedrine and N-Nitroso-pseudoephedrine in Pseudoephedrine Hydrochloride by HPLC-Tandem MS
|
|
2
|
527
|
August 28, 2025
|
|
Low recovery factor & Validation Issue
|
|
11
|
612
|
July 22, 2025
|
|
CMO Nitrosamine Risk Assessment
|
|
7
|
507
|
June 27, 2025
|
|
Nitrosamines in Carbamazepine?
|
|
5
|
960
|
June 27, 2025
|
|
👨💻 Quantitative Analysis of N-Nitrosodimethylamine in Metformin HCl by Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry
|
|
4
|
662
|
June 3, 2025
|
|
Separation of Nitrosamines and Ranitidine
|
|
3
|
239
|
May 27, 2025
|
|
N-nitroso Torasemide Impurity formation and control
|
|
33
|
2624
|
May 27, 2025
|
|
Cleaning procedure for glassware used in the analysis of nitrosamines for LC-MS/MS
|
|
2
|
415
|
May 23, 2025
|
|
N-Nitrosamine impurity of heterocyclic aromatic ring
|
|
17
|
4087
|
May 13, 2025
|
|
Total Nitrosamine Analyzer
|
|
3
|
315
|
May 12, 2025
|
|
Health Canada: Nitrosamine impurities Update July 26, 2024
|
|
16
|
1841
|
May 9, 2025
|
|
MDD for Metformin
|
|
4
|
332
|
May 2, 2025
|
|
🇰🇷 Korea NRA on 'Case Studies on Reducing Impurities in Pharmaceuticals (focusing on NDMA)"
|
|
0
|
342
|
May 1, 2025
|
|
Autonomous CPCA Web-based calculator FREE
|
|
33
|
6844
|
April 30, 2025
|
|
N-nitrosoamides - a horse of a different color
|
|
54
|
7379
|
March 6, 2025
|
|
To which nitrosamines does the CPCA apply?
|
|
2
|
602
|
February 6, 2025
|